Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alexandra Kropotova currently holds 44,284 shares of SAB Biotherapeutics, Inc. (SABS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexandra Kropotova has been a net neutral trader of SABS stock. They have purchased $0 and sold $0 worth of shares.
Alexandra Kropotova's most recent insider trade was on Dec 11, 2025, when they sold 988 shares at $0.00 per share.
Alexandra Kropotova serves as Executive at SAB Biotherapeutics, Inc. (SABS). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Alexandra Kropotova holds the position of Executive at SAB Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Alexandra Kropotova has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Alexandra Kropotova was on Dec 11, 2025, when they sold $0 worth of SABS shares. This transaction involved 988 shares at N/A per share.
Alexandra Kropotova currently owns 44,284 shares of SAB Biotherapeutics, Inc. (SABS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alexandra Kropotova's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alexandra Kropotova has 6 Form 4 filings on record as an insider at SAB Biotherapeutics, Inc..
Set alerts for Alexandra Kropotova and 40,000+ other insiders.